FLGT

18.69 -1.63%
Fulgent Genetics, Inc. NASDAQ Stock Healthcare Services Stocks
Open in Risen →

Fulgent Genetics, Inc. (FLGT) is listed on NASDAQ in the Services sector. This page tracks real-time FLGT price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.

Technical Analysis

RSI (14) 41.2 Neutral
Market Cap $514.3M
Volume 208.6K

Fundamentals — 10-Q Q2 2026

Revenue $156.5M
Net Income $-54.4M
EPS --
Gross Margin 30.1%
Operating Margin -45.2%
Net Margin -34.7%

Earnings

Recent Insider Trades

Name Title Type Shares Price Value Date
Xie Jian President and COO Sell 2,146 $17.89 $38,382 2026 Jun 2
Gao Hanlin Chief Scientific Officer Sell 1,688 $17.89 $30,191 2026 Jun 2
Xie Jian President and COO Sell 1,201 $17.60 $21,138 2026 May 27
Gao Hanlin Chief Scientific Officer Sell 945 $17.60 $16,632 2026 May 27
Gao Hanlin Chief Scientific Officer Sell 1,075 $28.33 $30,455 2025 Dec 2
Xie Jian President and COO Sell 1,140 $28.33 $32,296 2025 Dec 2
Xie Jian President and COO Sell 1,198 $29.57 $35,425 2025 Nov 28
Gao Hanlin Chief Scientific Officer Sell 943 $29.57 $27,885 2025 Nov 28
Gao Hanlin Chief Scientific Officer Sell 535 $30.47 $16,301 2025 Nov 24
Xie Jian President and COO Sell 681 $30.47 $20,750 2025 Nov 24
Xie Jian President and COO Sell 10,000 $29.10 $291,000 2025 Nov 19
Gao Hanlin Chief Scientific Officer Sell 1,063 $22.03 $23,418 2025 Sep 3
Xie Jian President and COO Sell 1,128 $22.03 $24,850 2025 Sep 3
Gao Hanlin Chief Scientific Officer Sell 943 $21.48 $20,256 2025 Aug 27
Xie Jian President and COO Sell 1,199 $21.48 $25,755 2025 Aug 27
Gao Hanlin Chief Scientific Officer Sell 548 $21.50 $11,782 2025 Aug 25
Xie Jian President and COO Sell 696 $21.50 $14,964 2025 Aug 25
Gao Hanlin Chief Scientific Officer Sell 754 $20.29 $15,299 2025 Jun 2
Xie Jian President and COO Sell 1,135 $20.29 $23,029 2025 Jun 2
Gao Hanlin Chief Scientific Officer Sell 1,039 $20.54 $21,343 2025 May 27

Take FLGT further

Set alerts on FLGT

Get notified when Fulgent Genetics, Inc. hits your price targets or technical conditions are met.

Get Started Free